IP Library Granted Patent US 9,902,973
Granted Patent B2
US 9,902,973 · App. 14/250,224 · Granted Feb 27, 2018

Methods of modifying a target nucleic acid with an argonaute

Inventors: John Van Der Oost (Renkum, NL); Daniël Christianus Swarts (Wageningen, NL); Andrew Paul May (San Francisco, CA); Rachel E. Haurwitz (Kensington, CA)
Assignee: Caribou Biosciences, Inc.
C12N15/902C12N15/10C12N15/102G01N33/542
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,902,973
App. No.
14/250,224
Granted
Feb 27, 2018
Kind
B2
Abstract

This disclosure provides for compositions and methods for the use of designed nucleic acid-targeting nucleic acids, Argonautes, and complexes thereof.

Claims (14)

1. A method of cutting a double-stranded DNA target sequence in a host cell in vitro, wherein the double-stranded DNA target sequence comprises a first DNA strand and a second DNA strand, the method comprising: introducing into the host cell:

a first complex comprising a first TtArgonaute protein and a first guide nucleic acid, wherein the first guide nucleic acid hybridizes with the first strand of the double-stranded DNA target sequence in the host cell and the first complex cuts the first strand of the double-stranded DNA target sequence, and

a second complex comprising a second TtArgonaute protein and a second guide nucleic acid, wherein the second guide nucleic acid hybridizes with the second strand of the double-stranded DNA target sequence in the host cell and the second complex cuts the second strand of the double-stranded DNA target sequence.

2. The method of claim 1 , wherein the first strand cut and the second strand cut of the double-stranded DNA target sequence are such that the cutting of the double-stranded DNA target sequence is a blunt-end cut.

3. The method of claim 1 , wherein the first strand cut and the second strand cut of the double-stranded DNA taret sequence are such that the cutting of the double-stranded DNA target sequence is a staggared-end cut.

4. The method of claim 1 , wherein the first guide nucleic acid and the second guide nucleic acid comprise DNA.

5. The method of claim 1 , wherein the first guide nucleic acid and the second guide nucleic acid comprise RNA.

6. The method of claim 5 , wherein the first guide nucleic acid and the second guide nucleic acid further comprise DNA.

7. The method of claim 1 , wherein the double-stranded DNA target sequence is within a genomic DNA of a cukaryotic host cell.

8. The method of claim 1 , wherein the host cell is a eukaryotic cell.

9. The method of claim 1 , wherein the host cell is a plant cell, an algal cell, a fungal cell, a cell from a vertebrate animal, or a cell from a mammal.

10. The method of claim 1 , wherein the introducing is carried out ex vivo.

11. The method of claim 1 , wherein the double-stranded DNA target sequence comprises DNA, the first guide nucleic acid comprises DNA, and the second guid nucleic acid comprises DNA.

12. The method of claim 11 , wherein the host cell is a eukaryotic cell.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2015
From: MAY, ANDREW PAUL; HAURWITZ, RACHEL E.
To: CARIBOU BIOSCIENCES, INC.
Reel/Frame 035365/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2015
From: VAN DER OOST, JOHN; SWARTS, DANIEL CHRISTIANUS
To: WAGENINGEN UNIVERSITEIT
Reel/Frame 035381/0405 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2015
From: WAGENINGEN UNIVERSITEIT
To: CARIBOU BIOSCIENCES, INC.
Reel/Frame 035381/0407 →
Priority Claims (1)
GB 1306574.3 · Apr 11, 2013 · national
Continuity (2)
Provisional Application 61939680 · Feb 13, 2014
Related Publication 20150089681A1 · Mar 26, 2015